Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Gross Margin (2021 - 2022)

Historic Gross Margin for SELLAS Life Sciences (SLS) over the last 3 years, with Q1 2022 value amounting to 90.0%.

  • SELLAS Life Sciences' Gross Margin fell 82500.0% to 90.0% in Q1 2022 from the same period last year, while for Dec 2022 it was 90.0%, marking a year-over-year decrease of 73700.0%. This contributed to the annual value of 90.0% for FY2022, which is 73700.0% down from last year.
  • SELLAS Life Sciences' Gross Margin amounted to 90.0% in Q1 2022, which was down 82500.0% from 94.74% recorded in Q2 2021.
  • SELLAS Life Sciences' 5-year Gross Margin high stood at 100.0% for Q4 2020, and its period low was 90.0% during Q1 2022.
  • In the last 3 years, SELLAS Life Sciences' Gross Margin had a median value of 96.49% in 2021 and averaged 95.75%.
  • The largest annual percentage gain for SELLAS Life Sciences' Gross Margin in the last 5 years was -82500bps (2022), contrasted with its biggest fall of -82500bps (2022).
  • Over the past 3 years, SELLAS Life Sciences' Gross Margin (Quarter) stood at 100.0% in 2020, then fell by -5bps to 94.74% in 2021, then decreased by -5bps to 90.0% in 2022.
  • Its last three reported values are 90.0% in Q1 2022, 94.74% for Q2 2021, and 98.25% during Q1 2021.